Brief: Acrux says U.S. Patent and Trademark Office institutes IPR proceeding against a U.S. Patent

KAKEN PHARMACEUTICAL

02/05/2017 02:15

May 2 (Reuters) - Acrux Ltd  ACR.AX  
    * U.S. Patent and Trademark Office has instituted an inter 
partes review (IPR) proceeding filed by Acrux against U.S. 
Patent no. 7,214,506 
    * Patent relates to methods of using various antifungal 
compounds, including efinaconazole, for treatment of 
onychomycosis 
    * U.S. Patent No. 7,214,506 is owned by Kaken Pharmaceutical 
Co Ltd. and licensed to Valeant Pharmaceuticals International 
Inc 
 
Source text for Eikon:  ID:nASX3RZK3z  
Further company coverage:  ACR.AX  
 
 ((Bangalore.newsroom@thomsonreuters.com;))